**Core Concept:**
The question tests our understanding of the most common red cell defects that are not associated with hemoglobin (Hb) abnormalities. These defects primarily affect the production, maturation, or function of red blood cells (RBCs).

**Why the Correct Answer is Right:**
The most common red cell defect without hemoglobin abnormality is **Sickle Cell Anemia**. In sickle cell anemia, the defect lies in the **beta-globin chain synthesis**, specifically in the production of hemoglobin (Hb) molecules. Hemoglobin is a protein found in RBCs that carries oxygen from the lungs to the rest of the body. In sickle cell anemia, a mutation in the HBB gene (which codes for the beta-globin chain) results in the production of abnormal hemoglobin molecules, called HbS (sickle hemoglobin). When the oxygen levels in the body decrease, these HbS molecules aggregate and cause the RBCs to become rigid and misshapen, resembling a sickle or crescent moon. This leads to reduced RBC deformability, shortened RBC lifespan, and impaired oxygen distribution, ultimately resulting in anemia.

**Why Each Wrong Option is Incorrect:**
A. **Thalassemias**: These are a group of inherited blood disorders caused by mutations in the globin genes (alpha-globin and beta-globin). Although thalassemias can affect RBCs, they are associated with hemoglobin abnormalities.
B. **Anaemia of chronic disease**: This is a type of anemia that occurs in response to chronic inflammation or infection. It is not a red cell defect but a compensatory response to reduced production or destruction of RBCs.
C. **Anaemia of chronic disease (ACD)**, also known as anemia of chronic inflammation, is a compensatory response to reduced RBC production or increased destruction. It is not a red cell defect.
D. **Anaemia of chronic disease**: This option is similar to B and C but with a slight rephrasing. It is still a compensatory response to reduced RBC production or increased destruction, not a red cell defect.

**Clinical Pearl:**
Understanding the distinction between red cell defects and compensatory responses to altered RBC production or destruction is essential in clinical practice. In sickle cell anemia, the defect lies in the red blood cells, whereas in thalassemias, anemia of chronic disease, and anemia of chronic inflammation, the response is a compensatory mechanism to an underlying issue.